Response to intravenous fentanyl infusion predicts subsequent response to transdermal fentanyl

Response to intravenous fentanyl infusion predicts subsequent response to transdermal fentanyl - Intravenous fentanyl before transdermal fentanyl

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018175

Enrollment

Registered

2015-07-03

Start date

2012-11-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain

Interventions

interview

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age from 20 to 85 body weight from 30 to 100kg pain persisting for more than 3 months more than 4 of NRS

Exclusion criteria

Exclusion criteria: psychiatric disease serious chronic disease such as cardiac failure, pulmonary emphysema, and interstitial hepatitis skin problems that might affect transdermal delivery life-limiting conditions

Design outcomes

Primary

Measure	Time frame
numerical rating scale clinical global impression improvement scale satisfaction scale	—

Countries

Japan

Contacts

Public ContactNorihito Hayashi

Kitasato University School of Medicine Anesthesiology

mininoriton@ybb.ne.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026